We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03598270
Recruitment Status : Active, not recruiting
First Posted : July 26, 2018
Last Update Posted : February 8, 2022
Sponsor:
Collaborators:
Hoffmann-La Roche
GlaxoSmithKline
AGO Study Group
Belgian Gynaecological Oncology Group
ARCAGY/ GINECO GROUP
Israeli Society of Gynecologic Oncology
MaNGO
Information provided by (Responsible Party):
Grupo Español de Investigación en Cáncer de Ovario